Valsartan: Updates and Challenges

Rami Kariv, Ministry of Health, Israel
Zipi Hess, Ministry of Health, Israel

Regulatory Authorities received from June 2018 information that some (val)sartan products were contaminated with N-nitrosodimethylamine (NDMA)
and with N-nitrosodiethylamine (NDEA), known as possible carcinogen for humans. Those contaminations far exceeded regulatory exposure limits.


Organized & Produced by:

www.isranalytica.org.il

POB 4043, Ness Ziona 70400, Israel
Tel.: +972-8-9313070, Fax: +972-8-9313071
Site: www.bioforum.co.il,
E-mail: bioforum@bioforum.co.il